Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Carbonylation | 6 | 2015 | 10 | 1.890 |
Why?
|
| Oxidative Stress | 5 | 2011 | 473 | 1.360 |
Why?
|
| Proteomics | 7 | 2017 | 268 | 1.210 |
Why?
|
| Blood Proteins | 3 | 2011 | 151 | 0.730 |
Why?
|
| Proteins | 2 | 2015 | 816 | 0.520 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2011 | 110 | 0.500 |
Why?
|
| Tetracycline | 1 | 2015 | 13 | 0.450 |
Why?
|
| Drugs, Generic | 1 | 2014 | 21 | 0.440 |
Why?
|
| Fatty Liver | 1 | 2015 | 108 | 0.410 |
Why?
|
| Tacrolimus | 1 | 2014 | 373 | 0.400 |
Why?
|
| Sulfinic Acids | 1 | 2011 | 2 | 0.360 |
Why?
|
| Oncogene Proteins | 1 | 2011 | 65 | 0.350 |
Why?
|
| Hemoglobins | 1 | 2011 | 193 | 0.340 |
Why?
|
| Biotin | 4 | 2011 | 46 | 0.340 |
Why?
|
| Cysteine | 1 | 2011 | 146 | 0.330 |
Why?
|
| Antioxidants | 1 | 2011 | 232 | 0.320 |
Why?
|
| Liver | 1 | 2015 | 1231 | 0.310 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 995 | 0.310 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 396 | 0.310 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 847 | 0.300 |
Why?
|
| Pharmacogenetics | 1 | 2012 | 456 | 0.280 |
Why?
|
| Models, Molecular | 1 | 2010 | 1375 | 0.240 |
Why?
|
| Oxidation-Reduction | 3 | 2011 | 411 | 0.240 |
Why?
|
| Genetic Variation | 1 | 2012 | 1422 | 0.230 |
Why?
|
| Peptide Fragments | 3 | 2011 | 477 | 0.220 |
Why?
|
| Trypsin | 3 | 2011 | 95 | 0.190 |
Why?
|
| Rats, Zucker | 2 | 2011 | 38 | 0.180 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2011 | 82 | 0.170 |
Why?
|
| Mutation | 1 | 2011 | 4374 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 517 | 0.140 |
Why?
|
| Peptides | 2 | 2011 | 671 | 0.130 |
Why?
|
| Cisplatin | 1 | 2017 | 599 | 0.110 |
Why?
|
| Rats | 2 | 2011 | 4154 | 0.110 |
Why?
|
| Therapeutic Equivalency | 1 | 2014 | 16 | 0.110 |
Why?
|
| Drug Substitution | 1 | 2014 | 28 | 0.110 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 58 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 193 | 0.100 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 368 | 0.090 |
Why?
|
| Transplantation, Homologous | 1 | 2014 | 1023 | 0.090 |
Why?
|
| Humans | 8 | 2017 | 95795 | 0.090 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 205 | 0.090 |
Why?
|
| Tea | 1 | 2011 | 19 | 0.090 |
Why?
|
| Isoprostanes | 1 | 2011 | 3 | 0.090 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2011 | 2 | 0.090 |
Why?
|
| Methionine | 1 | 2011 | 68 | 0.090 |
Why?
|
| Oxidants | 1 | 2011 | 86 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2011 | 52 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 165 | 0.090 |
Why?
|
| Chromatography, Gel | 1 | 2010 | 105 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 102 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 27 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 336 | 0.080 |
Why?
|
| Hydrazines | 1 | 2010 | 33 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 81 | 0.080 |
Why?
|
| Avidin | 1 | 2010 | 5 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2011 | 201 | 0.080 |
Why?
|
| Glycation End Products, Advanced | 1 | 2010 | 12 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 47 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 84 | 0.080 |
Why?
|
| Molecular Structure | 1 | 2010 | 310 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 286 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2061 | 0.070 |
Why?
|
| Animals | 3 | 2015 | 28887 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 416 | 0.070 |
Why?
|
| Carcinoma | 1 | 2011 | 444 | 0.070 |
Why?
|
| Infant | 1 | 2014 | 3360 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2010 | 301 | 0.070 |
Why?
|
| Genome, Human | 1 | 2012 | 824 | 0.070 |
Why?
|
| Smoking | 1 | 2011 | 649 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1957 | 0.060 |
Why?
|
| Male | 3 | 2015 | 45684 | 0.060 |
Why?
|
| Phenotype | 1 | 2012 | 2575 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1809 | 0.050 |
Why?
|
| Adult | 2 | 2011 | 28578 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 3155 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 317 | 0.030 |
Why?
|
| Middle Aged | 1 | 2011 | 28207 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2777 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2010 | 71 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2010 | 42 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 180 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2010 | 88 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 509 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 426 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 935 | 0.020 |
Why?
|
| Female | 1 | 2011 | 49870 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2383 | 0.020 |
Why?
|